Berenberg Bank Reiterates “Buy” Rating for Advanced Medical Solutions Group (LON:AMS)

Advanced Medical Solutions Group (LON:AMS)‘s stock had its “buy” rating reissued by analysts at Berenberg Bank in a research note issued to investors on Thursday, MarketBeat Ratings reports. They currently have a GBX 300 price target on the stock. Berenberg Bank’s price target points to a potential upside of 33.33% from the company’s current price.

Separately, Peel Hunt reissued a “buy” rating and issued a GBX 246 price objective on shares of Advanced Medical Solutions Group in a research note on Wednesday, September 17th. Three investment analysts have rated the stock with a Buy rating, Based on data from MarketBeat, Advanced Medical Solutions Group presently has an average rating of “Buy” and an average target price of GBX 273.67.

Advanced Medical Solutions Group Stock Up 0.4%

Shares of LON:AMS opened at GBX 225 on Thursday. Advanced Medical Solutions Group has a fifty-two week low of GBX 168.40 and a fifty-two week high of GBX 248.50. The firm’s 50 day moving average price is GBX 215.37 and its 200 day moving average price is GBX 212.50. The company has a quick ratio of 4.58, a current ratio of 8.39 and a debt-to-equity ratio of 37.01. The stock has a market cap of £486.80 million, a price-to-earnings ratio of 53.96, a price-to-earnings-growth ratio of 5.00 and a beta of 0.74.

About Advanced Medical Solutions Group

AMS is a world-leading independent developer and manufacturer of innovative tissue-healing technology, focused on quality outcomes for patients and value for payers. AMS has a wide range of surgical products including tissue adhesives, sutures, haemostats, internal fixation devices and internal sealants, which it markets under its brands LiquiBand®, RESORBA®, LiquiBandFix8®, and Seal-G®. AMS also supplies wound care dressings such as silver alginates, alginates and foams through its ActivHeal® brand as well as under white label.